INmune Bio Inc.

NASDAQ: INMB · Real-Time Price · USD
2.53
0.08 (3.27%)
At close: Aug 15, 2025, 3:59 PM
2.47
-2.37%
After-hours: Aug 15, 2025, 07:51 PM EDT

INmune Bio Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.21 -6.75 -4.16 -5.42
PEG Ratio
-0.08 -0.68 0.22 -0.06
PS Ratio
6.65K 1.31K 303.90 909.04
PB Ratio
2.90 5.31 1.89 2.05
P/FCF Ratio
-2.79 -16.9 -5.01 -3.78
P/OCF Ratio
-2.79 -16.9 -5.01 -5.77
OCF/S Ratio
-2.38K -77.29 -60.66 -157.48
Debt / Equity Ratio
0.01 0.27 0.25 0.19
Quick Ratio
3.14 2.16 5.92 20.21
Current Ratio
3.14 2.16 5.92 18.95
Asset Turnover
0.00 0.00 0.00 0.00
Interest Coverage
n/a n/a -19.25 n/a
Return on Equity
-1.31 -0.79 -0.45 -0.38
Return on Assets
-1.06 -0.53 -0.33 -0.3
Return on Invested Capital
-1.31 -0.61 -0.34 -0.3
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00 1.00
Net Profit Margin
-3.01K -193.6 -72.99 -167.62
Pretax Profit Margin
-3.01K -193.6 -72.99 -167.62
Operating Profit Margin
-3.05K -191.88 -69.39 -161.07
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-3.01K -191.88 -69.39 -161.07